- ADJUNCT ASSISTANT PROFESSOR Oncological Sciences
- ADJUNCT ASSISTANT PROFESSOR Urology
Dr. Hayley Thompson is an assistant professor at Mount Sinai School of Medicine with joint appointments in the Program for Cancer Prevention and Control/Department of Oncological Sciences and the Department of Urology. Her primary research focus is understanding and addressing ethnic/racial disparities in cancer. Within this focus, Dr. Thompson has completed investigations of the role of medical mistrust in breast cancer screening among African Americans and Latinas and has developed and published a measure of medical mistrust. She is also currently investigating issues of patient-provider communication, language proficiency, and health outcomes in multiethnic patient and community samples.
Additionally, Dr. Thompson is the principal investigator of two funded research studies. The first is an Department of Defense (DoD) Breast Cancer Research Program Idea Award to develop an intervention to increase post-treatment breast cancer surveillance among African American breast cancer survivors and evaluate that intervention through a randomized controlled trial. The second is a DoD Prostate Cancer Research Program Health Disparity Research -Prostate Scholar Award to create culturally appropriate prostate cancer educational materials to increase early detection of prostate cancer among African American men. These materials will also be evaluated through a randomized trial.
Dr. Thompson is also co-investigator on two projects to develop and evaluate culturally sensitive genetic counseling and education for African American women at high risk for breast cancer, including an interactive decision aid (CD-ROM) for this population.
Thompson HS, Valdimarsdottir H, Duteau-Buck C, Guevarra J, Scott D, Richmond-Avellaneda C, Amarel D, Godfrey D, Scheueer L, Offit K. Factors Associated with BRCA Counseling and Testing Decisions Among Urban African American Women. Cancer Epidemiology, Biomarkers and Prevention 2002 Dec; 11(12): 1579-1585.
Thompson HS, Kamarck TW, Manuck SB. The association between racial identity and hypertension in African American adults: Elevated resting and ambulatory blood pressure as outcomes. Ethnicity & Disease 2002; 12(1): 20-28.
Thompson HS, Valdimarsdottir H, Jandorf L, Redd W. Perceived Disadvantages and Potential Abuses of Genetic Testing for Cancer Risk Among African American, Latina and Caucasian Women. Patient Education and Counseling 2003; 51: 217-227.
Thompson HS, Wahl E, Fatone A, Brown K, Kwate NO, Valdimarsdottir H. Enhancing the Readability of Materials Describing Genetic Risk for Breast Cancer. Cancer Control 2004 Jul-Aug; 11(4): 245-253.
Thompson HS, Valdimarsdottir H, Jandorf LR, Redd W. The Group-Based Medical Mistrust Scale: Psychometric Properties and Association with Breast Cancer Screening. Preventive Medicine 2004 Feb; 38(2): 209-218.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Thompson is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 2nd floor, CPC
1425 Madison Avenue
New York, NY 10029